Hemorrhagic Transformation in Acute Ischemic Stroke
- 1 May 1997
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 28 (5) , 957-960
- https://doi.org/10.1161/01.str.28.5.957
Abstract
Background and Purpose Recent studies suggest that thrombolytic therapy may be of benefit to patients with acute ischemic stroke. However, the treatment also carries a significant risk of hemorrhagic transformation (HT). The purpose of this study was to select potential contributors to HT.Keywords
This publication has 13 references indexed in Scilit:
- Hemorrhagic transformation of brain infarctNeurology, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Acute Stroke — On the Threshold of a Therapy?New England Journal of Medicine, 1995
- Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic strokeThe Lancet, 1995
- Intravenous Thrombolysis With Recombinant Tissue Plasminogen Activator for Acute Hemispheric StrokeJAMA, 1995
- Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarctionNeurology, 1995
- European Cooperative Acute Stroke Study (ECASS): (rt‐PA—Thrombolysis in acute stroke) study design and progress reportEuropean Journal of Neurology, 1995
- Cerebral amyloid angiopathy: A significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderlyJournal of the Neurological Sciences, 1993
- Recombinant tissue plasminogen activator in acute thrombotic and embolic strokeAnnals of Neurology, 1992
- Thrombolytic Agents in the Treatment of StrokeClinical Neuropharmacology, 1990